These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20193980)

  • 1. Efficacy of moxidectin microsphere sustained release formulation for the prevention of subcutaneous filarial (Dirofilaria repens) infection in dogs.
    Genchi M; Pengo G; Genchi C
    Vet Parasitol; 2010 May; 170(1-2):167-9. PubMed ID: 20193980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of an injectable, sustained-release formulation of moxidectin in preventing experimental heartworm infection in mongrel dogs challenged 12 months after administration.
    Lok JB; Knight DH; Nolan TJ; Grubbs ST; Cleale RM; Heaney K
    Vet Parasitol; 2005 Mar; 128(1-2):129-35. PubMed ID: 15725542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month prophylactic efficacy of moxidectin sustained release (SR) injectable for dogs against experimental heartworm infection in growing puppies.
    Lok JB; Washabau RJ; Heaney K; Nolan TJ; Hendrick MJ; Neumann NR; Ulrich M
    Vet Parasitol; 2005 Oct; 133(2-3):233-41. PubMed ID: 16085364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.
    Genchi C; Genchi M; Petry G; Kruedewagen EM; Schaper R
    Parasitol Res; 2013 Aug; 112 Suppl 1():81-9. PubMed ID: 23774842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
    Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
    Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full season efficacy of moxidectin microsphere sustained release formulation for the prevention of heartworm (Dirofilaria immitis) infection in dogs.
    Genchi C; Rossi L; Cardini G; Kramer LH; Venco L; Casiraghi M; Genchi M; Agostini A
    Vet Parasitol; 2002 Dec; 110(1-2):85-91. PubMed ID: 12446092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety evaluation of moxidectin sustained-release injectable in 10-week-old puppies.
    Heaney K; Lindahl RG
    Vet Parasitol; 2005 Oct; 133(2-3):227-31. PubMed ID: 16171949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of ProHeart
    Bowman DD; McTier TL; Adams EL; Mahabir SP; Login JA; Bidgood T; Woods DJ
    Parasit Vectors; 2017 Nov; 10(Suppl 2):502. PubMed ID: 29143654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis.
    Lok JB; Knight DH; Wang GT; Doscher ME; Nolan TJ; Hendrick MJ; Steber W; Heaney K
    Am J Vet Res; 2001 Nov; 62(11):1721-6. PubMed ID: 11703014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent efficacy of moxidectin canine sustained-release injectable against experimental infections of Ancylostoma caninum and Uncinaria stenocephala in dogs.
    Bowman DD; Rock T; Heaney K; Neumann NR; Ulrich M; Amodie D
    Vet Ther; 2003; 4(3):228-33. PubMed ID: 15136983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of moxidectin 6-month injectable and milbemycin oxime/lufenuron tablets against naturally acquired trichuris vulpis infections in dogs.
    Bowman DD; Legg W; Stansfield DG
    Vet Ther; 2002; 3(3):286-9. PubMed ID: 12447836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a single administration of a spot-on solution containing imidacloprid 10%/moxidectin 2.5% in eliminating Dirofilaria repens microfilariae in naturally infected dogs.
    Traversa D; Aste G; Di Cesare A; Paoletti B; Di Tommaso M; Di Giulio E; Pampurini F; Tunesi C; Boari A
    Vet Parasitol; 2011 Jun; 179(1-3):107-12. PubMed ID: 21435791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months.
    McTier TL; Kryda K; Wachowski M; Mahabir S; Ramsey D; Rugg D; Mazaleski M; Therrien C; Adams E; Wolff T; Bowman DD
    Parasit Vectors; 2019 Jul; 12(1):369. PubMed ID: 31349867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfilaricidal efficacy of a single administration of Advocate(®) (Bayer Animal Health) in dogs naturally infected with Dirofilaria immitis or Dirofilaria repens.
    Frangipane di Regalbono A; Di Cesare A; Traversa D; Simonato G; Poser H; Danesi P; Furnari C; Russi I; Raele DA; Crisi P; Pampurini F; Pietrobelli M
    Vet Parasitol; 2016 Aug; 226():30-4. PubMed ID: 27514879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of moxidectin 6-month injectable and milbemycin oxime/lufenuron tablets against naturally acquired toxocara canis infections in dogs.
    Bowman DD; Legg W; Stansfield DG
    Vet Ther; 2002; 3(3):281-5. PubMed ID: 12447835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs.
    Alberigi B; Fernandes JI; Paiva JP; Mendes-de-Almeida F; Knackfuss F; Merlo A; Labarthe N
    Parasit Vectors; 2020 Oct; 13(1):503. PubMed ID: 33023664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
    Arther RG; Bowman DD; Slone RL; Travis LE
    Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Dirofilaria immitis infection in dogs: effects of doxycycline and Advantage Multi® administration on immature adult parasites.
    Chandrashekar R; Beall MJ; Saucier J; O'Connor T; McCall JW; McCall SD
    Vet Parasitol; 2014 Nov; 206(1-2):93-8. PubMed ID: 25218886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a single injection of a sustained-release formulation of moxidectin for prevention of experimental heartworm infection after 12 months in dogs.
    Holm-Martin M; Atwell R
    Am J Vet Res; 2004 Nov; 65(11):1596-9. PubMed ID: 15566101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs.
    McCall JW; Arther R; Davis W; Settje T
    Vet Parasitol; 2014 Nov; 206(1-2):86-92. PubMed ID: 25444277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.